In our lung cancer bioinformatic analysis of TF RUNX2 [48], we analyzed and compared our pipeline and results [38,49] with previous studies, finding eleven publications assessing the lung cancer TRN with different microarray and RNA-seq studies; we also performed direct and very different bioinformatics analyses on datasets created or selected from the databases. This evidence concerns the gene RUNX2 and lung cancer.